Blood Gas and Electrolyte Analyzers Market to Be Dominated by Portable/Hand-Held Automated Devices

Blood gas and electrolyte analyzers are used to check for a variety of disorders in the bloodstream. Blood gas analyzers measure partial pressure of oxygen in a patient’s blood while electrolyte analyzers measure the concentration of vital elements such as sodium, potassium, and calcium. These popular diagnostic devices uses along with other tests help in accurate diagnosis of various chronic conditions such as asthma, chronic obstructive pulmonary disease (COPD), kidney failure, heart failure, uncontrolled diabetes, severe infections, and drug overdose. The global blood gas and electrolyte analyzers market is projected to register a CAGR of 9% from USD 1.7 billion in 2017 to over USD 3 billion by 2026, driven by the growing preference for portable or hand-held automated analyzers.

These are the latest findings of Transparency Market Research (Wilmington, DE, USA), a global market research company.

Currently, technological advancements, an increase in chronic illnesses and a rising elderly population are driving the growth of the global blood gas and electrolyte analyzers market. Advanced analyzers have reduced turnaround time and enhance patient care by providing accurate results. Going forward, advanced analyzers with reduced turnover time and enhanced efficiency and productivity are expected to drive the demand for blood gas and electrolyte analyzers over the next few years. The global market is expected to be further driven by an increase in the number of patients treated in NICUs, ICUs, and emergency departments, as well as a rise in patients battling various chronic illnesses. Increased investments in healthcare by governments around the world are also expected to contribute to the growth of the global blood gas and electrolyte analyzers market. However, the shortage of skilled health care professionals in the developing regions for operating advanced blood gas analysis devices and the complexities associated in interpreting blood analysis results is likely to hamper market growth.

Based on product type, the combination analyzers segment held a majority of share of the global blood gas and electrolyte analyzers market in terms of revenue in 2017. The paradigm shift from traditional central laboratory blood gas analyzers to point-of-care testing devices and rise in demand for multi-parameter monitoring are expected to propel the growth of the combination analyzers segment. Based on region, North America accounted for the largest share of the global blood gas and analyzers market in 2017, followed by Europe. North America is expected to maintain its dominant position due to its well-developed healthcare industry and the existence of top blood gas and electrolyte analyzer producers in the region, while the increased adoption of advanced technologies and large geriatric population in Germany will propel the growth of the market in Europe.

The market for blood gas and electrolyte analyzers in Asia Pacific is likely to offer significant growth opportunities, owing to rising awareness about blood disorders and procedures for employing these analyzers, increasing incidence of chronic diseases and greater need for testing analyzers in newly constructed hospitals in the region, and increased focus of key players in its emerging markets such as China and India.

Related Links:
Transparency Market Research